Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.50
Bid: 53.00
Ask: 56.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.66%)
Open: 54.50
High: 54.50
Low: 54.50
Prev. Close: 54.50
BVT Live PriceLast checked at -
Baronsmead Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Allotment,Total Voting Rights,Close of Offer

28 Mar 2024 11:00

RNS Number : 7160I
Baronsmead Venture Trust PLC
28 March 2024

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY MEMBER STATE OF THE EEA (OTHER THAN ANY MEMBER STATE OF THE EEA WHERE THE COMPANY'S SECURITIES MAY BE LEGALLY MARKETED), OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO ISSUE OR SELL, OR ANY SOLICITATION OF ANY OFFER TO SUBSCRIBE OR PURCHASE, ANY INVESTMENTS IN ANY JURISDICTION.

Baronsmead Venture Trust plc

LEI: 213800VQ1PQHOJXDDQ88

28 March 2024

Allotment of Shares, Total Voting Rights and Close of Offer

The Board of Baronsmead Venture Trust plc (the "Company") announced on 24 November 2023 that the Company, together with Baronsmead Second Venture Trust plc, had published a prospectus (the "Prospectus") in relation to offers for subscription to raise up to £30 million in aggregate with the discretion to utilise over-allotment facilities to raise up to a further £20 million in aggregate (the "Offers" and each an "Offer").

On 19 March 2024 (the "Close Date"), the Company announced that the Offer was closed to new subscriptions and that no further Applications for New Shares would be accepted.

On 28 March 2024 and in accordance with the Allotment Formula set out in the Prospectus, the Company allotted 19,051,906 Ordinary Shares of 10 pence each (the "New Ordinary Shares") in the capital of the Company pursuant to the third and final allotment under the Offer conditional only on Admission (the timetable for which is set out in more detail below). The New Ordinary Shares were issued at prices of between 56.80 pence per New Ordinary Share and 59.56 pence per New Ordinary Share, depending on the amount of Offer Costs, any Initial Commission waived, any Initial Adviser Charges, any Early Bird Discount associated with an Application and based on the net asset value per Ordinary Share as at 29 February 2024 (being the last published net asset value per Ordinary Share as announced on 6 March 2024).

Application will shortly be made for the New Ordinary Shares to be admitted to the premium segment of the Official List of the Financial Conduct Authority and to trading on the premium segment of London Stock Exchange plc's main market for listed securities ("Admission"). It is expected that Admission will occur and dealing will commence in the New Ordinary Shares on or around 3 April 2024. When issued, the New Ordinary Shares will rank pari passu with the existing Ordinary Shares.

As a result of the issue, the total number of Ordinary Shares in issue will be 391,292,410 (excluding the 33,172,409 Ordinary Shares currently held in Treasury) with each Ordinary Share carrying one vote each. Therefore, the total voting rights in the Company will be 391,292,410. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

The New Ordinary Shares will be issued in registered form and may be held in uncertificated form. Definitive documents of title are expected to be dispatched within 10 business days of allotment. The New Ordinary Shares will be eligible for settlement through CREST with effect from Admission.

Unless the context requires otherwise, terms defined in the Prospectus have the same meaning where used in this announcement.

For the avoidance of doubt, the Offer in respect of the Company is now closed but the Offer in respect of Baronsmead Second Venture Trust plc remains open.

For further information please contact:

Baronsmead VCT Investor Relations

020 7382 0999

baronsmeadvcts@greshamhouse.com

Important Information

This Announcement is an advertisement for the purposes of the Prospectus Regulation Rules of the UK Financial Conduct Authority ("FCA") and is not a prospectus. This Announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription of, or solicitation of any offer to subscribe for or to acquire, any ordinary shares in Baronsmead Venture Trust plc or Baronsmead Second Venture Trust plc (together the "Companies") in any jurisdiction, including in or into Australia, Canada, Japan, the Republic of South Africa, the United States or any member state of the EEA (other than any member state of the EEA where the Companies' securities may be lawfully marketed). Investors should not subscribe for or purchase any ordinary shares referred to in this Announcement except on the basis of information in the prospectus (the "Prospectus") in its final form, published on 24 November 2023 by Baronsmead Venture Trust plc and Baronsmead Second Venture Trust plc, together with the supplementary prospectus published on 19 January 2024 (the "Supplementary Prospectus"), in connection with the Offer. A copy of the Prospectus and Supplementary Prospectus is available for inspection, subject to certain access restrictions, from the Company's registered office, for viewing at the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website (http://www.baronsmeadvcts.co.uk). Approval of the Prospectus and Supplementary Prospectus by the FCA should not be understood as an endorsement of the securities that are the subject of the Prospectus and Supplementary Prospectus. Potential investors are recommended to read the Prospectus and Supplementary Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with a decision to invest in the Companies' securities.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IOEPPUCCWUPCGUR
Date   Source Headline
29th Nov 20059:38 amRNSDoc re. Interim Report
25th Nov 20054:04 pmRNSTransaction in Own Shares
21st Nov 200511:43 amRNSNet Asset Value(s)
11th Nov 20054:24 pmRNSInterim Results
16th Sep 200511:15 amRNSTransaction in Own Shares
9th Sep 20053:48 pmRNSNet Asset Value(s)
23rd Aug 20053:40 pmRNSTransaction in Own Shares
19th Aug 200511:23 amRNSNet Asset Value(s)
14th Jul 20054:22 pmRNSDirector/PDMR Shareholding
14th Jul 20054:21 pmRNSDirector/PDMR Shareholding
14th Jul 20054:15 pmRNSDirector/PDMR Shareholding
7th Jul 200510:19 amRNSDirector/PDMR Shareholding
7th Jul 200510:18 amRNSDirector/PDMR Shareholding
7th Jul 200510:14 amRNSDirector/PDMR Shareholding
6th Jul 200511:58 amRNSOrdinary Shares
6th Jul 200511:50 amRNSC Shares
6th Jul 200510:22 amRNSIssue of Equity
28th Jun 200511:09 amRNSChange of Auditors
7th Jun 20051:58 pmRNSBlocklisting Interim Review
6th Jun 20052:20 pmRNSTransaction in Own Shares
20th May 20054:43 pmRNSTransaction in Own Shares
19th May 20052:38 pmRNSDividend Declaration
18th May 200512:15 pmRNSFinal Results
4th May 20052:42 pmRNSDividend Declaration
18th Apr 20055:08 pmRNSHolding(s) in Company
30th Mar 200510:00 amRNSTransaction in Own Shares
1st Mar 20054:34 pmRNSTransaction in Own Shares
24th Feb 20051:59 pmRNSTransaction in Own Shares
17th Feb 20054:53 pmRNSHolding(s) in Company
15th Feb 200510:57 amRNSNet Asset Value(s)
21st Jan 200511:56 amRNSHolding(s) in Company
14th Jan 20051:05 pmRNSOffer for Subscription Update
12th Jan 200511:55 amRNSTransaction in Own Shs-Amend
11th Jan 20053:32 pmRNSTransaction in Own Shares
10th Jan 20052:58 pmRNSIssue of Equity
7th Jan 20053:52 pmRNSC Share Issue
5th Jan 20054:34 pmRNSTransaction in Own Shares
4th Jan 20053:00 pmRNSC Share Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.